“Omics” Application in Heart Failure: Novel Diagnostic and Prognostic Markers to Understand Pathophysiology and Find New Therapies
Author:
Marín-García José
Reference56 articles.
1. Moe GW (2005) BNP in the diagnosis and risk stratification of heart failure. Heart Fail Monit 4:116–122
2. Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A et al (2006) NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients The International Collaborative of NT-proBNP Study. Eur Heart J 27:330–337
3. Januzzi JL Jr, Camargo CA, Anwaruddin S, Baggish AL et al (2005) The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95:948–954
4. Maisel AS, Krishnaswamy P, Nowak RM, McCord J et al (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161–167
5. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, Tunstall-Pedoe H, McMurray JJ, Dargie HJ (1998) Biochemical detection of left-ventricular systolic dysfunction. Lancet 351:9–13